DEXADENT

This brand name is authorized in Poland

Active ingredients

The drug DEXADENT contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII E2287TKU04 - DEXAMETHASONE ACETATE, UNSPECIFIED FORM
 

Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response.

 
Read more about Dexamethasone
2
UNII Y3720KZ4TQ - FRAMYCETIN SULFATE
 
Read more about Framycetin
3
UNII 19371312D4 - POLYMYXIN B SULFATE
 

Polymixin B is bactericidal against a wide range of gram negative bacilli. It exerts a bactericidal effect by binding to acid phospholipids in the cell wall and membranes of the bacterium, thereby rendering ineffective the osmotic barrier normally provided by the cell membrane.

 
Read more about Polymyxin B

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A01AD Other agents for local oral treatment A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations
Discover more medicines within A01AD

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
PL Rejestru Produktów Leczniczych 100114433

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.